Invesco’s Lyell Immunopharma LYEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-98,649
Closed -$3.04M 3790
2025
Q4
$3.04M Buy
+98,649
New +$2.21M ﹤0.01% 2447
2025
Q3
Sell
-12,809
Closed -$113K 3829
2025
Q2
$113K Sell
12,809
-6,135
-32% -$55.9K ﹤0.01% 3636
2025
Q1
$204K Sell
18,944
-1,416
-7% -$17.3K ﹤0.01% 3506
2024
Q4
$261K Buy
20,360
+63
+0.3% +$1.25K ﹤0.01% 3457
2024
Q3
$560K Sell
20,297
-46
-0.2% -$1.35K ﹤0.01% 3186
2024
Q2
$590K Sell
20,343
-127
-0.6% -$6.05K ﹤0.01% 3207
2024
Q1
$913K Buy
20,470
+4,915
+32% +$210K ﹤0.01% 3034
2023
Q4
$604K Buy
15,555
+919
+6% +$33.1K ﹤0.01% 3123
2023
Q3
$430K Buy
14,636
+103
+0.7% +$4.89K ﹤0.01% 3272
2023
Q2
$924K Buy
14,533
+74
+0.5% +$4.09K ﹤0.01% 2934
2023
Q1
$682K Buy
14,459
+11,675
+419% +$624K ﹤0.01% 3103
2022
Q4
$193K Sell
2,784
-12,766
-82% -$1.27M ﹤0.01% 3693
2022
Q3
$2.28M Buy
15,550
+12,744
+454% +$1.73M ﹤0.01% 2583
2022
Q2
$366K Sell
2,806
-128
-4% -$13.1K ﹤0.01% 3488
2022
Q1
$296K Buy
2,934
+2,357
+408% +$286K ﹤0.01% 3640
2021
Q4
$89K Buy
+577
New +$129K ﹤0.01% 3917

Other funds holding LYEL